Mechanistically, C-C motif chemokine ligand 5 (CCL5) secreted by pericytes activates C-C motif chemokine receptor 5 (CCR5) on GBM cells, enabling DDR mediated by DNA-dependent protein kinase catalytic subunits (DNA-PKcs) after TMZ treatment. This evidence concerns the gene CCR5 and glioblastoma.